February 28, 2024 — New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indica ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
February 27, 2024 — Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the ...
February 26, 2024 — More than 6 million Americans live with heart failure, and about half have an enlarged left ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
February 22, 2024 — Wake Forest University School of Medicine, the academic core of Advocate Health, is expanding ...
February 21, 2024 — Ochsner Children's Hospital, ranked among the top hospitals in the nation for pediatric cardiology a ...
February 20, 2024 — As New Jersey’s leading provider of high-quality cardiac procedures and diagnostic testing and an ...
February 15, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and ...
February 15, 2024 — Research findings in a clinical trial led by a professor at the University of Tennessee Health ...
February 15, 2024 — Canary Medical, a medical data company focused on the development and commercialization of its ...
February 12, 2023 — A team at Allina Health Minneapolis Heart Institute at Abbott Northwestern Hospital has successfully ...
February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association’s Internation ...
February 6, 2024 — A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The ...
February 6, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...
February 1, 2024 —  Genomics plc (Genomics), a healthcare company aiming to transform health through the power of ...